Enzon Pharmaceuticals, Inc. (ENZN)

OTCMKTS: ENZN · Delayed Price · USD
0.0948
0.00 (0.00%)
Apr 10, 2024, 10:28 AM EDT - Market closed
Market Cap 7.04M
Revenue (ttm) n/a
Net Income (ttm) 1.37M
Shares Out 74.21M
EPS (ttm) 0.00
PE Ratio 72.92
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 16
Open 0.0924
Previous Close 0.0948
Day's Range 0.0924 - 0.0948
52-Week Range 0.0600 - 0.2300
Beta 0.33
Analysts n/a
Price Target n/a
Earnings Date Mar 18, 2013

About ENZN

Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey. [Read more]

Industry Biotechnology
Sector Healthcare
IPO Date Feb 15, 1984
Country United States
Stock Exchange OTCMKTS
Ticker Symbol ENZN
Full Company Profile

Financial Performance

Financial Statements

News

Enzon Pharmaceuticals, Inc. CEO Andrew Rackear to Retire; Richard L. Feinstein, Enzon's CFO, to Assume Position of CEO and Remain CFO

CRANFORD, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTC:ENZN) announced today that Andrew Rackear has communicated to the Board his intent to retire from his role as the Com...

3 years ago - GlobeNewsWire

Enzon Pharmaceuticals Announces Results of Rights Offering

Looking to Next Step – Acquisition Opportunities Looking to Next Step – Acquisition Opportunities

3 years ago - GlobeNewsWire

Enzon Pharmaceuticals Announces Key Dates for Rights Offering

CRANFORD, N.J., Sept. 15, 2020 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (the “Company” or “Enzon”) (OTC:ENZN) announced today the record date and expected subscription period for its previous...

3 years ago - GlobeNewsWire

Enzon Pharmaceuticals, Inc. Announces Postponement of 2020 Annual Meeting

CRANFORD, N.J., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (the “Company” or “Enzon”) (OTC:ENZN) today announced that its 2020 annual meeting of stockholders (the “Annual Meeting...

3 years ago - GlobeNewsWire

Enzon Pharmaceuticals Anticipated Rights Offering to Existing Shareholders

CRANFORD, N.J., Aug. 21, 2020 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (the “Company” or “Enzon”) (OTC: ENZN) today announced that its Board of Directors (the “Board”) has approved a rights o...

3 years ago - GlobeNewsWire

Enzon Pharmaceuticals, Inc. Adopts Tax Benefits Preservation Plan to Protect its NOL Assets and Shareholder Value

CRANFORD, N.J., Aug. 14, 2020 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (the “Company” or “Enzon”) (OTC:ENZN) today announced that its Board of Directors (the “Board”) adopted a tax benefits p...

3 years ago - GlobeNewsWire